CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$0.48
-0.02 (-3.97%)
Open$0.51
Previous Close$0.50
Day High$0.53
Day Low$0.48
52W High$3.62
52W Low$0.49
Volume—
Avg Volume1.93M
Market Cap44.47M
P/E Ratio—
EPS$-0.42
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+4,792.6% upside
Current
$0.48
$0.48
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.12M | 24.12M | 28.34M |
| Net Income | 5.84M | 5.30M | 5.57M |
| Profit Margin | 21.6% | 22.0% | 19.7% |
| EBITDA | 7.13M | 6.78M | 8.30M |
| Free Cash Flow | 3.88M | 4.04M | 6.28M |
| Rev Growth | -4.2% | +22.6% | +13.0% |
| Debt/Equity | 1.37 | 0.99 | 1.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |